Skip to main content
. 2010 Jul 29;2010:196963. doi: 10.1155/2010/196963

Table 5.

Baseline laboratory evaluation prior to receiving HIV nPEP medications.

Cohort N = 151
Liver transaminases ≥2 SD 0 (0)
Hematocrit <35% 17 (11)
Hematocrit <30% 3 (2)
Thrombocytopenia (150,000 platelets) 0 (0)
Glucose >200 mg% 2 (1)
Hypophosphatemia 1 (1)
Creatinine >1.2 mg/mL 0 (0)
Hepatitis C seropositive 5 (3)
HIV seropositive 0 (0)
Hepatitis B surface antigen 0 (0)